Polycystic metabolic ovary syndrome (PMOS/PCOS)-like phenotype score and its correlates among women in India
Objective Polycystic ovary syndrome (PCOS), was recently renamed polycystic metabolic ovary syndrome (PMOS) to emphasize its metabolic underpinnings. PMOS/PCOS is typically clinically managed through a narrow lens across different specialties, frequently overlooking systemic metabolic complications. The metabolic complications of PMOS/PCOS are particularly relevant in developing countries such as India, where obesity is increasing. Additionally, PMOS/PCOS remains highly under-detected and under-treated in India. Using data from the nationally representative National Family Health Survey (NFHS)-5, we developed an exploratory composite PMOS/PCOS-like phenotype score to characterize population-level distribution and associated health burdens. Material and methods We conducted a cross-sectional analysis of NFHS-5 data among women aged 20–40 years. For each woman, three domain-specific scores, glucose-related, anthropometric/metabolic, and ovarian, were estimated using clinically relevant indicators available in the dataset and aggregated into a PMOS/PCOS-like phenotype score. From a sample of over 700,000 women, 299,886 women had complete information for the study. Women were categorized into high, moderate, and low score groups, and associations between the PMOS/PCOS-like phenotype score and sociodemographic factors, noncommunicable diseases (NCDs), reproductive, maternal and social outcomes, and geographic variation were examined. Results The PMOS/PCOS scoring classified 3.69% of women into the high-score group, 29.41% into the moderate-score group, and 66.90% into the low-score group. Socioeconomic factors correlated with higher PMOS/PCOS-like phenotype scores, with higher prevalence found among urban, highly educated, and wealthier women. The phenotype score was associated with primary infertility, stillbirth and cesarean delivery. Women in the high-score group exhibited a higher prevalence of nearly all self-reported NCDs, including diabetes, cancer, and heart disease. Importantly, states with higher Human Development Index (HDI) showed a greater prevalence of the high-score group. Conclusion This cross-sectional analysis of an analytical sample derived from the nationally representative NFHS-5 survey demonstrates that a multidimensional PMOS/PCOS-like phenotype score that specifically takes into account the metabolic component is strongly correlated with PMOS/PCOS-related features and co-morbidity burdens at the population level. The associations of higher PMOS/PCOS-like phenotype scores with reproductive and maternal outcomes and chronic disease burden highlights the need for life-course perspective in clinical care. A strong positive association between PMOS/PCOS-like phenotype score with HDI score is also noted.
Authors
- Priyanka Mehra
- Anagha Joshi
Institutions
- University of Bergen (NO)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fpubh.2026.1986580
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00